rs2291703
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_133433.4(NIPBL):āc.1151A>Gā(p.Asn384Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000353 in 1,614,030 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N384D) has been classified as Likely benign.
Frequency
Consequence
NM_133433.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIPBL | NM_133433.4 | c.1151A>G | p.Asn384Ser | missense_variant | 9/47 | ENST00000282516.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIPBL | ENST00000282516.13 | c.1151A>G | p.Asn384Ser | missense_variant | 9/47 | 1 | NM_133433.4 | P1 | |
NIPBL | ENST00000448238.2 | c.1151A>G | p.Asn384Ser | missense_variant | 9/46 | 1 | |||
NIPBL | ENST00000652901.1 | c.1151A>G | p.Asn384Ser | missense_variant | 9/46 | ||||
NIPBL | ENST00000504430.5 | n.771A>G | non_coding_transcript_exon_variant | 5/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000916 AC: 23AN: 251026Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135648
GnomAD4 exome AF: 0.000371 AC: 542AN: 1461790Hom.: 9 Cov.: 32 AF XY: 0.000391 AC XY: 284AN XY: 727192
GnomAD4 genome AF: 0.000184 AC: 28AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74434
ClinVar
Submissions by phenotype
Cornelia de Lange syndrome 1 Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 23, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at